ANATOMIC STAGE IV BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE IV BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE IV BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fish oil pills tested in fight against rare, aggressive breast cancer
Disease control TerminatedThis early-phase study tested whether combining a prescription fish oil (icosapent ethyl) with the cancer drug dasatinib could help control a rare and aggressive form of breast cancer that had spread. The goal was to find a safe dose and see if the combination could shrink tumors…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Trial halted early: targeted combo tested for tough breast cancer
Disease control TerminatedThis study aimed to see if adding a new drug called copanlisib to standard treatments could better control advanced HER2-positive breast cancer in people with specific genetic changes. It was designed to first find a safe dose and then test if the three-drug combination could kee…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists test Four-Pronged attack on tough breast cancer
Disease control TerminatedThis study tested four different drug combinations to see if they could help control advanced triple-negative breast cancer that had spread. It involved 24 patients and aimed to see if pairing a drug called olaparib with other targeted medicines, or using a single new drug, could…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Gordon Mills, MD, PhD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Two-Pronged attack tested against brain tumors
Disease control TerminatedThis early-phase study tested a combination of two drugs, bintrafusp alfa and pimasertib, for patients with cancer that had spread to the brain (brain metastases). The goal was to find a safe dose and see if the combination could help control the brain tumors and help patients li…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Can texting about fasting help fight brain cancer?
Disease control TerminatedThis study tested whether a mobile app that guides patients through a time-restricted eating schedule could help protect their memory and thinking skills and improve survival after radiation treatment for brain metastases. The trial was designed for adults with breast or lung can…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Targeted combo trial for tough breast cancer halted early
Disease control TerminatedThis study tested if adding a targeted drug called binimetinib to standard hormone therapy (fulvestrant) could better control advanced breast cancer that has a specific genetic change (NF1). It aimed to see if the combination could shrink tumors more effectively or keep the cance…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC